EPKINLY® for 3L+ DLBCL and FL

EPKINLY® (epcoritamab-bysp) is a bispecific antibody given by subcutaneous injection for adults with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) that returned or didn't respond after 2 or more prior treatments. See Important Safety Information, full Prescribing Information & Medication Guide, and Boxed Warnings.

The power of EPKINLY makes sustained remission possible
Now FDA approved for earlier treatment in follicular lymphoma (FL)

FDA approved for 2 types of lymphoma that returned or didn't respond after 2 or more prior treatments
What is EPKINLY?
What is EPKINLY?
IMPORTANT SAFETY INFORMATION
You are leaving the product website.
You are leaving the product website.
You are leaving the product website.
Leaving Genmab & AbbVie Website
You are about to enter a site that is for US healthcare professionals only.
What is EPKINLY?

0.77319502830505